Sudden Sensorineural Hearing Loss after Third Dose Booster of COVID-19 Vaccine Administration
Authors:
- Federica ZoccaliFZFederica Zoccali
- Francesca CambriaFCFrancesca Cambria
- Andrea ColizzaACAndrea Colizza
- Massimo RalliMassimo Ralli
- Antonio GrecoAntonio Greco
- Marco de VincentiisMVMarco de Vincentiis
- Carla PetrellaCPCarla Petrella
- Marco FioreMarco Fiore
- Antonio MinniAntonio Minni
- Christian BarbatoCBChristian Barbato
Open Access
- 23 August 2022
- journal article
- case report
- Published by MDPI AG in Diagnostics
- Vol. 12 (9) , 2039
Abstract
Coronavirus disease 2019 (COVID-19) was declared a pandemic due to its rapid spread worldwide, and its vaccination campaign is considered one of the most historic public hygiene measures in modern medicine. Sudden sensorineural hearing loss (SSHL) is a common emergency that affects patient’s quality of life and requires rapid treatment with steroids. The etiology could be viral or vascular even though in most cases it remains unknown (idiopathic SSHL). During the SARS-CoV-2 vaccination campaign, several rare but serious adverse events have been reported including thrombosis with thrombocytopenia syndrome, myocarditis, and Guillain-Barré Syndrome. ENT adverse events after vaccination were reported too, including cases of sudden sensorineural hearing loss (SSHL), vestibular neuronitis and audio vestibular disorders (such as tinnitus, dizziness, and vertigo). For the first time here, we reported two cases of SSHL after third administration of COVID-19 mRNA vaccine. Even if there is not clear evidence of an association between SSHL and vaccination, adverse effects should be kept in mind since viral infection could be the etiology of SSHL.Keywords
This publication has 18 references indexed in Scilit:
- Corticosteroid Use in Otolaryngology: Current Considerations During the COVID‐19 EraOtolaryngology–Head and Neck Surgery, 2021
- Sudden sensorineural hearing loss after COVID-19 vaccinationInternational Journal of Infectious Diseases, 2021
- Sudden Sensorineural Hearing Loss Following the Second Dose of COVID-19 VaccineCureus, 2021
- Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices — United States, July 2021MMWR. Morbidity and Mortality Weekly Report, 2021
- Efficacy of Intratympanic Glucocorticoid Steroid Administration Therapy as an Initial Treatment for Idiopathic Sudden Sensorineural Hearing Loss During the COVID-19 PandemicEar, Nose & Throat Journal, 2021
- Otologic Manifestations After COVID-19 Vaccination: The House Ear Clinic ExperienceOtology & Neurotology, 2021
- Preliminary Analysis of Association Between COVID-19 Vaccination and Sudden Hearing Loss Using US Centers for Disease Control and Prevention Vaccine Adverse Events Reporting System DataJAMA Otolaryngology–Head & Neck Surgery, 2021
- SARS-CoV-2 vaccines and autoimmune diseases amidst the COVID-19 crisisRheumatology International, 2021
- Sudden irreversible hearing loss post COVID-19BMJ Case Reports, 2020
- Sudden‐Onset Sensorineural Hearing Loss after ImmunizationOtolaryngology–Head and Neck Surgery, 2016